Home › Calculator › MDGL Dividend Calculator 2026
MDGL Dividend DRIP Calculator 2026
0.36% YieldHealthcareMadrigal Pharmaceuticals, Inc. · NASDAQ
Price: $550.25 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MDGL pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your MDGL snowball 📈
$10,000 in MDGL → $10.4K in 10 years · $3.13/month
About Madrigal Pharmaceuticals, Inc. (MDGL) — Dividend Analysis 2026
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for managing non-alcoholic steatohepatitis (NASH). The company's pipeline also features MGL-3745, which serves as a secondary or backup compound to resmetirom. Madrigal holds a collaborative agreement with Hoffmann-La Roche, encompassing research, development, and commercialization activities. The company's operations are based out of West Conshohocken, Pennsylvania.
Compare MDGL with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MDGL DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MDGL position with:
🌍 MDGL Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MDGL.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.36% | -2.44% | $36 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.31% | -2.49% | $31 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.29% | -2.51% | $29 / yr |
| 🇬🇧 UK ISA | 0% | 0.36% | -2.44% | $36 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.33% | -2.47% | $33 / yr |
| 🇨🇦 TFSA | 0% | 0.36% | -2.44% | $36 / yr |
| 🇨🇦 CA Taxable | 25% | 0.27% | -2.53% | $27 / yr |
| 🇦🇺 Super (pension) | 15% | 0.31% | -2.49% | $31 / yr |
| 🇦🇺 AU Taxable | 30% | 0.25% | -2.55% | $25 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.27% | -2.53% | $27 / yr |
| 🇫🇷 FR Taxable | 30% | 0.25% | -2.55% | $25 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MDGL Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MDGL Dividend Payment Schedule
MDGL pays quarterly — 4 times per year. Next ex-div: TBD.
📊 MDGL vs Healthcare Benchmarks
How MDGL compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MDGL sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MDGL Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-07-17 | 50,000 | — | — | ||
| Sale | 2026-07-20 | 140 | $542.75 | $76.0K | ||
| Sale | 2026-07-20 | 110 | $543.79 | $59.8K | ||
| Sale | 2026-07-20 | 545 | $544.71 | $296.9K | ||
| Sale | 2026-07-20 | 275 | $545.71 | $150.1K | ||
| Sale | 2026-07-20 | 269 | $547.08 | $147.2K | ||
| Sale | 2026-07-20 | 680 | $547.70 | $372.4K | ||
| Sale | 2026-07-20 | 47 | $548.87 | $25.8K | ||
| Sale | 2026-07-20 | 153 | $550.01 | $84.2K | ||
| Sale | 2026-07-20 | 1 | $550.72 | $551.00 |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MDGL dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Madrigal Pharmaceuticals, Inc. (MDGL) is currently trading at $550.25, 7% below its 52-week high. The current dividend yield is 0.36% based on an annual payout of $2.00 per share.
MDGL (Madrigal Pharmaceuticals, Inc.) — 0.36% Dividend Yield Analysis
Madrigal Pharmaceuticals, Inc. (MDGL) is a healthcare stock currently trading at $550.25 with a dividend yield of 0.36%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.